Lead Product(s) : Diperoxochloric Acid
Therapeutic Area : Podiatry
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Centaur Pharma Launches Novel Topical Solution WoxHeal for the Treatment of Diabetic Foot Ulcer
Details : WOXheal has dual mechanism of action, i.e. it has functional antibacterial action against Gram positive and gram negative bacteria and it also promotes growth of fibroblast cells, thereby yielding complete wound closure.
Brand Name : WOXheal
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 08, 2020
Lead Product(s) : Diperoxochloric Acid
Therapeutic Area : Podiatry
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?